In brief Life sciences, regulatory and intellectual property COVID-19 suvey on: market access clinical trials IP risks telemedicine Contents Market access Clinical trials IP risks Telemedicine Market access (a) How has the regulator in charge been addressing the urgent needs for medicines, medical devices and medical supplies? Has the focus…
Author
Gabriela Paiva-Morette
BrowsingGabriela Paiva Morette is a partner in the IPTech group and focuses on TMT matters. She received a master of laws degree from Kings College London. Worked at the London office of Baker & McKenzie in 2011, in the Intellectual Property practice group.